AREV Life Sciences Global Corp.

Equities

AREV

CA04019J1093

Food Processing

Market Closed - Canadian Securities Exchange 12:06:40 2023-07-11 pm EDT 5-day change 1st Jan Change
0.09 CAD -10.00% Intraday chart for AREV Life Sciences Global Corp. -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
AREV Life Sciences Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
AREV Life Sciences Global Corp. (CNSX : AREV) cancelled the acquisition of Fiberlab, Inc. CI
AREV Life Sciences Global Corp. cancelled the transaction announced on March 14, 2023 CI
AREV Life Sciences Global Corp. (CNSX : AREV) entered into letter on intent to acquire Fiberlab, Inc for $7 million. CI
AREV Life Sciences Global Corp. announced that it expects to receive CAD 7.548 million in funding CI
AREV Life Sciences Global Corp. Announces the Resignation of Melvin Maxwell from Board CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
AREV Life Sciences Global Corp. Announces Management Changes CI
AREV Life Sciences Global Corp. Announces the Appointment of Sateesh Apte to the Scientific Advisory Board CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
AREV Life Sciences Global Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
AREV Life Sciences Global Corp. Auditor Raises 'Going Concern' Doubt CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
AREV Life Sciences Appoint Kevin Phelps COO MT
AREV Life Sciences Global Corporation Announces Engagement of TransBIOTech to Facilitate Preclinical Therapeutic Pipeline Development CI
AREV Life Sciences Global Corporation Appoints Brian V. Elliott to its Board of Directors CI
AREV Life Sciences Global Corp. Appoints Kevin Phelps as Chief Operating Officer CI
AREV Life Sciences Global Corp. Completes Lab and Fungi Fruiting Room Build CI
AREV Life Sciences Global Corp. Appoints Douglas Sorocco to Its Scientific Advisory Committee CI
AREV Life Sciences Global Corp. Announces Executive Changes CI
AREV Life Sciences Global Corp Appoints Allan Echino as Director CI
AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Chart AREV Life Sciences Global Corp.
More charts
AREV Life Sciences Global Corp. is a Canada-based fully integrated, early-stage life science discovery company. The Company produces ingredients and formulates therapeutic interventions with plans to deliver innovation in clinical nutrition, supplements, topicals and rational drug design, based on science. Its business model leverages its core competency of extraction to produce ingredients and compounds for its pipeline of products. The Company’s nutraceutical product formulations seek to be sold under its BARE and Wright and Well brands or produced for third parties on a licensed white label basis. Its BARE and Wright and Well Brands of finished products include natural health products, including cannabidiol (CBD)-infused products such as Canna-Mulsion and NaturVax, an anti- viral supplement; NaturRelax, a natural Sleep Aid; Natur Relief, an anti- inflator and pain relief product, and a line of CBD skincare products and medicinal oils and edibles.
More about the company
  1. Stock Market
  2. Equities
  3. AREV Stock
  4. News AREV Life Sciences Global Corp.
  5. AREV NanoTec Brands : Nanotech Brands Inc. and Germinator Sign Distribution Agreement For Surface Disinfectant, Air Filtration Systems